Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 8/20 | 0.72 |
| ▸ | KDM1A | O60341 | 1/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | KIF11 | P52732 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL919670 | 0.94 | ELANE (0.66) | ELANEKDM1AHSD17B10CA2MEN1 | |
| SCHEMBL978959 | 0.94 | ELANE (0.66) | ELANEKDM1AHSD17B10CA2MEN1 | |
| SCHEMBL4061370 | 0.94 | ELANE (0.81) | ELANEKDM1ACA2MEN1KMT2A | |
| SCHEMBL4060624 | 0.93 | ELANE (0.64) | ELANEKDM1AHSD17B10CA2MEN1 | |
| SCHEMBL14878467 | 0.91 | ELANE (0.62) | ELANEKDM1AHSD17B10CA2MEN1 | |
| SCHEMBL3985477 | 0.91 | ELANE (0.62) | ELANEKDM1AHSD17B10CA2MEN1 | |
| SCHEMBL12240209 | 0.91 | ELANE (0.62) | ELANEKDM1AHSD17B10CA2MEN1 | |
| SCHEMBL7705585 | 0.89 | ELANE (0.60) | ELANEKDM1AHSD17B10CA2MEN1 | |
| SCHEMBL13616226 | 0.88 | ELANE (0.58) | ELANEKDM1ACA2MEN1KMT2A | |
| SCHEMBL13845252 | 0.88 | ELANE (0.58) | ELANEKDM1AHSD17B10CA2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9778569-B2 | Positive photosensitive resin composition, method for producing film using same, and electronic component | CENTRAL GLASS COMPANY, LIMITED (JP) | 2017-10-03 | — | — | US | disclosed |
| US-20160266491-A1 | Positive Photosensitive Resin Composition, Method for Producing Film Using Same, and Electronic Component | CENTRAL GLASS COMPANY, LIMITED (JP) | 2016-09-15 | — | — | US | disclosed |
| US-8980525-B2 | Chemically amplified positive resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2015-03-17 | — | — | US | disclosed |
| US-20130022926-A1 | RADIATION-SENSITIVE RESIN COMPOSITION | JSR CORPORATION (JP) | 2013-01-24 | — | — | US | disclosed |
| US-7534547-B2 | Optically active compound and photosensitive resin composition | OSAKA GAS COMPANY LIMITED (JP) | 2009-05-19 | — | — | US | disclosed |
| US-7534547-B2 | Optically active compound and photosensitive resin composition | OSAKA GAS COMPANY LIMITED (JP) | 2009-05-19 | — | — | US | disclosed |
| US-6841334-B2 | Onium salts and positive resist materials using the same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2005-01-11 | — | — | US | disclosed |
| EP-1375463-A1 | OPTICALLY ACTIVE COMPOUND AND PHOTOSENSITIVE RESIN COMPOSITION | Kansai Research Institute, Inc. (JP) | 2004-01-02 | — | — | EP | disclosed |
| US-20030211421-A1 | Optically active compound and photosensitive resin composition | KRI, INC. (JP) | 2003-11-13 | — | — | US | disclosed |
| EP-0615163-B1 | Positive resist material using particular onium salts | SHINETSU CHEMICAL CO (JP) | 1999-12-29 | — | — | EP | disclosed |
| EP-0615163-A1 | Onium salts and positive resist materials using the same | Shin-Etsu Chemical Co., Ltd. (JP) | 1994-09-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030211421-A1 | Optically active compound and photosensitive resin composition | ARCN1, RAD51, PAM | ELANE 422/4885KDM1A 113/4885HSD17B10 3699/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.